The genomics tool producer has raised more than $100m from investors including General Electric and Myriad Genetics.
US-based genomics tools developer RainDance Technologies filed for an initial public offering on Friday and will seek to raise up to $60m.
RainDance produces and sells systems, consumables and assays for the ultra-sensitive detection and analysis of complex genetic diseases. It made an $8.8m net loss in 2014 from revenues of $30.6m.
RainDance’s investors include GE Ventures, the corporate venturing subsidiary of conglomerate General Electric which provided $16.5m in series E funding to it in 2013 together with private…
